Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-02-16
DOI
10.3389/fimmu.2017.00056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway
- (2016) Bailong Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma
- (2016) Federica Felicetti et al. Journal of Translational Medicine
- miR-221 attenuates the osteogenic differentiation of human annulus fibrosus cells
- (2016) Ching-Hua Yeh et al. Spine Journal
- MicroRNA-19b/221/222 induces endothelial cell dysfunction via suppression of PGC-1α in the progression of atherosclerosis
- (2015) Yunxing Xue et al. ATHEROSCLEROSIS
- A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
- (2015) A. Gulla et al. CLINICAL CANCER RESEARCH
- ThemicroRNA-221/-222cluster balances the antiviral and inflammatory response in viral myocarditis
- (2015) Maarten Corsten et al. EUROPEAN HEART JOURNAL
- MicroRNA-221 regulates endothelial nitric oxide production and inflammatory response by targeting adiponectin receptor 1
- (2015) Chao-Feng Chen et al. GENE
- Effects of microRNA-221/222 on cell proliferation and apoptosis in prostate cancer cells
- (2015) Lina Wang et al. GENE
- MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer
- (2015) Hyun Jin Bae et al. JOURNAL OF HEPATOLOGY
- Downregulation of microRNA-221 decreases migration and invasion in fibroblast-like synoviocytes in rheumatoid arthritis
- (2015) SHUZHONG YANG et al. Molecular Medicine Reports
- Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma
- (2015) Rui Zhang et al. MOLECULAR NEUROBIOLOGY
- Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
- (2015) Ryoichi Tanaka et al. PLoS One
- miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases
- (2015) Qinhong Xu et al. Oncotarget
- Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling
- (2015) Dmitry A. Chistiakov et al. Biomed Research International
- miR-221 and miR-222 Simultaneously Target RECK and Regulate Growth and Invasion of Gastric Cancer Cells
- (2015) Wenneng Liu et al. MEDICAL SCIENCE MONITOR
- In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma
- (2015) Maria Teresa Di Martino et al. Oncotarget
- Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
- (2014) Yifang Wei et al. BREAST CANCER RESEARCH AND TREATMENT
- microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma
- (2014) T O Yau et al. BRITISH JOURNAL OF CANCER
- Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
- (2014) R Gan et al. CANCER GENE THERAPY
- miR-221/222 Confers Radioresistance in Glioblastoma Cells Through Activating Akt Independent of PTEN Status
- (2014) W. Li et al. CURRENT MOLECULAR MEDICINE
- A microRNA 221– and 222–Mediated Feedback Loop Maintains Constitutive Activation of NFκB and STAT3 in Colorectal Cancer Cells
- (2014) Sanhong Liu et al. GASTROENTEROLOGY
- MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer
- (2014) Henrique Faneca et al. International Journal of Nanomedicine
- Expression Profiles of Six Circulating MicroRNAs Critical to Atherosclerosis in Patients With Subclinical Hypothyroidism: A Clinical Study
- (2014) Xinhuan Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221
- (2014) Eleonora Brognara et al. JOURNAL OF NEURO-ONCOLOGY
- Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer
- (2014) Zhengchuan Fu et al. MEDICAL ONCOLOGY
- miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer
- (2014) Yuan Li et al. MOLECULES
- Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties
- (2014) XING-XING HE et al. ONCOLOGY REPORTS
- In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells
- (2014) Maria Teresa Di Martino et al. PLoS One
- Down-Regulation of mir-221 and mir-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1
- (2014) Xiao Yang et al. PLoS One
- Effects of Multiple-target Anti-microRNA Antisense Oligodeoxyribonucleotides on Proliferation and Migration of Gastric Cancer Cells
- (2013) Ling Xu et al. Asian Pacific Journal of Cancer Prevention
- Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro
- (2013) Minhua Rong et al. BMC CANCER
- MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
- (2013) N Falkenberg et al. BRITISH JOURNAL OF CANCER
- Beyond Secondary Structure: Primary-Sequence Determinants License Pri-miRNA Hairpins for Processing
- (2013) Vincent C. Auyeung et al. CELL
- Mechanism of miRNA-mediated repression of mRNA translation
- (2013) Tamas Dalmay Essays in Biochemistry
- MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK
- (2013) Jun Qin et al. FEBS LETTERS
- In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
- (2013) Flavia Pichiorri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Expression and Clinical Significance of GTP-Binding RAS-Like 3 (ARHI) and MicroRNA 221 and 222 in Prostate Cancer
- (2013) D Lin et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Increased Expression of MicroRNA-221 in Gastric Cancer and Its Clinical Significance
- (2013) K Liu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis
- (2013) ChongLek Lee et al. MEDICAL ONCOLOGY
- p53/mdm2 Feedback Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma
- (2013) Francesca Fornari et al. MOLECULAR CANCER RESEARCH
- MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A
- (2013) T Sun et al. ONCOGENE
- miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer
- (2013) Michael S. Hwang et al. PLoS One
- miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
- (2013) Cristina Quintavalle et al. PLoS One
- Anti-miRNA-221 sensitizes human colorectal carcinoma cells to radiation by upregulating PTEN
- (2013) Qi Xue WORLD JOURNAL OF GASTROENTEROLOGY
- Advances with microRNAs in Parkinson’s disease research
- (2013) Weien Yuan et al. Drug Design Development and Therapy
- Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model
- (2012) Ioannis Pandis et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular Targets for the Treatment of Multiple Myeloma
- (2012) Marco Rossi et al. CURRENT CANCER DRUG TARGETS
- Exploiting the therapeutic potential of microRNAs in human cancer
- (2012) William CS Cho EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis
- (2012) Tomohiro Ogawa et al. GUT
- Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model
- (2012) Elisa Callegari et al. HEPATOLOGY
- High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
- (2012) Chunzhi Zhang et al. Journal of Translational Medicine
- Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma
- (2012) Jing-jing Huang et al. MEDICAL ONCOLOGY
- Identification of Serum MicroRNAs as Novel Non-Invasive Biomarkers for Early Detection of Gastric Cancer
- (2012) Ming-yang Song et al. PLoS One
- MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma
- (2011) Kai Sun et al. ACTA PHARMACOLOGICA SINICA
- Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
- (2011) Jipeng Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
- (2011) T. A. Farazi et al. CANCER RESEARCH
- Role of microRNA-221/-222 in cancer development and progression
- (2011) Tong Sun et al. CELL CYCLE
- MicroRNA changes in human arterial endothelial cells with senescence: Relation to apoptosis, eNOS and inflammation
- (2011) Catarina Rippe et al. EXPERIMENTAL GERONTOLOGY
- Nucleolin Protein Interacts with Microprocessor Complex to Affect Biogenesis of MicroRNAs 15a and 16
- (2011) Brian F. Pickering et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker
- (2011) Hisashi Kanemaru et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ
- (2011) C Quintavalle et al. ONCOGENE
- Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status
- (2011) Chuanlu Jiang ONCOLOGY REPORTS
- The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer
- (2011) Tong Sun et al. PROSTATE
- miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer
- (2011) S. Stinson et al. Science Signaling
- MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
- (2010) Zhang Chun-zhi et al. BMC CANCER
- MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer
- (2010) Y. Chen et al. Cancer Prevention Research
- A MicroRNA Targeting Dicer for Metastasis Control
- (2010) Graziano Martello et al. CELL
- Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- (2010) Xing-xiang Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
- (2010) Gianpiero Di Leva et al. JNCI-Journal of the National Cancer Institute
- Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma
- (2010) Xinhui Fu et al. MOLECULAR BIOLOGY REPORTS
- MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
- (2010) Chun-Zhi Zhang et al. Molecular Cancer
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- Role of Specific MicroRNAs in Regulation of Vascular Smooth Muscle Cell Differentiation and the Response to Injury
- (2010) Zifang Song et al. Journal of Cardiovascular Translational Research
- Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
- (2009) M. Lionetti et al. BLOOD
- Proteolytic Cleavage of Protein Tyrosine Phosphatase Regulates Glioblastoma Cell Migration
- (2009) A. M. Burgoyne et al. CANCER RESEARCH
- The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
- (2009) T. Sun et al. CANCER RESEARCH
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
- (2009) L. Gramantieri et al. CLINICAL CANCER RESEARCH
- Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease
- (2009) Y. Minami et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles
- (2009) Marta Lionetti et al. GENES CHROMOSOMES & CANCER
- MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
- (2009) William C.S. Cho INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo
- (2009) Kang INTERNATIONAL JOURNAL OF ONCOLOGY
- PTPμ suppresses glioma cell migration and dispersal
- (2009) Adam M. Burgoyne et al. NEURO-ONCOLOGY
- Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer
- (2009) Young-Kook Kim et al. NUCLEIC ACIDS RESEARCH
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival
- (2008) R. Medina et al. CANCER RESEARCH
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
- (2008) Jian-Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA involvement in hepatocellular carcinoma
- (2008) Laura Gramantieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
- (2008) Neri Mercatelli et al. PLoS One
- Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real-Time PCR Analysis
- (2008) Yuqing Zhang et al. WORLD JOURNAL OF SURGERY
- Targeting microRNA expression to regulate angiogenesis
- (2007) Angelika Kuehbacher et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now